The Innovative Medicines Initiative (IMI) has launched its 7th Call for proposals under IMI2.
The call will be managed in two stage and composed of seven topics:
• Topic 1: Validation of translational imaging methods in drug safety assessment (TRISTAN)
• Topic 2: Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases
• Topic 3: Pathological neuron-glia interactions in neuropathic pain
• Topic 4: Dry age-related macular degeneration: development of novel clinical endpoints for clinical trials with a regulatory and patient access intention
• Topic 5: A comprehensive ‘paediatric preclinical POC platform’ to enable clinical molecule development for children with cancer
Topics under the Big Data for Better Outcomes programme:
• Topic 6: Coordination and support action (CSA) for the big data better outcomes programme
• Topic 7: Increase access and use of high quality data to improve clinical outcomes in heart failure (HF), atrial fibrillation (AF), and acute coronary syndrome (ACS) patients
The deadline for proposals of first stage is 5 p.m on 17 March 2016.
For detailed information: http://www.h2020.org.tr/tr/haber/imi-2-7cagrisi